These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17938752)

  • 41. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.
    Pinto DS; Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Mehran R; Na Y; Turco M; Caputo R; Popma JJ; Cutlip DE; Russell ME; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(1):32-6. PubMed ID: 16814645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes.
    Lemos PA; van Mieghem CA; Arampatzis CA; Hoye A; Ong AT; McFadden E; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Circulation; 2004 Jun; 109(21):2500-2. PubMed ID: 15148279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
    Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
    J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents.
    Liu J; Maehara A; Mintz GS; Weissman NJ; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Stone GW
    Am J Cardiol; 2009 Feb; 103(4):501-6. PubMed ID: 19195510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent).
    Ellis SG; Stone GW; Cox DA; Hermiller J; O'Shaughnessy C; Mann T; Turco M; Caputo R; Bergin PJ; Bowman TS; Baim DS;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1248-59. PubMed ID: 20129552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
    Rittger H; Brachmann J; Sinha AM; Waliszewski M; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Breithardt OA; Schmidt M; Zimmermann S; Lonke S; von Cranach M; Nguyen TV; Daniel WG; Wöhrle J
    J Am Coll Cardiol; 2012 Apr; 59(15):1377-82. PubMed ID: 22386286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
    Silber S; Colombo A; Banning AP; Hauptmann K; Drzewiecki J; Grube E; Dudek D; Baim DS
    Circulation; 2009 Oct; 120(15):1498-504. PubMed ID: 19786634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sirolimus-versus paclitaxel-eluting stents: a comparison of two consecutive series in routine clinical practice.
    Katritsis DG; Korovesis S; Karabinos I; Giazitzoglou E; Theodorou S; Karvouni E; Voridis E
    J Interv Cardiol; 2006 Feb; 19(1):31-7. PubMed ID: 16483337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracoronary radiotherapy with a 188Rhenium liquid-filled angioplasty balloon system in in-stent restenosis: a single-center, prospective, randomized, placebo-controlled, double-blind evaluation.
    Reynen K; Kropp J; Köckeritz U; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
    Coron Artery Dis; 2006 May; 17(4):371-7. PubMed ID: 16707961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
    Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness and determinants of the long-term beta intracoronary brachytherapy results.
    Witkowski A; Kalińczuk Ł; Chmielak Z; Łyczek J; Pregowski J; Kawczyńska M; Bulski W; Kulik A; Kepka C; Kruk M; Pszona S; Rózyłło W
    Kardiol Pol; 2005 Jun; 62(6):545-557; discussion 558. PubMed ID: 16123848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I).
    Grube E; Silber S; Hauptmann KE; Buellesfeld L; Mueller R; Lim V; Gerckens U; Russell ME
    Am J Cardiol; 2005 Jul; 96(1):79-82. PubMed ID: 15979439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients.
    Di Mario C; Morici N; Godino C; Goktekin O; Tamburino C; Barbagallo R; Antoniucci D; Grube E; Airoldi F; Zoccai GB; Colombo A; Sangiorgi GM
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):416-24. PubMed ID: 17191238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions.
    Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Violini R; Dibie A; Berti S; Maupas E; Antoniucci D; Schofer J
    J Am Coll Cardiol; 2012 Apr; 59(15):1371-6. PubMed ID: 22284328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis].
    Chen JL; Yang YJ; Qiao SB; Yao M; Qin XW; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):305-7. PubMed ID: 17711652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
    Ellis SG; O'Shaughnessy CD; Martin SL; Kent K; McGarry T; Turco MA; Kereiakes DJ; Popma JJ; Friedman M; Koglin J; Stone GW;
    Eur Heart J; 2008 Jul; 29(13):1625-34. PubMed ID: 18556716
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials.
    Halkin A; Stone GW
    J Interv Cardiol; 2004 Oct; 17(5):271-82. PubMed ID: 15491330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.